BMYBristol-Myers Squibb Company

$59.06
$-0.52 (-1%)

Bristol-Myers Squibb Company (BMY) Stock Analysis

Create a FREE Account to View Full BMY Stock Report

Bristol-Myers Squibb Company (BMY) Analyst Forecast

Next 12 months ➝Current Price$59.0652-week High$68.3452-week Low$42.48MEAN$66.22+12.13%HIGH$75.00+26.99%LOW$53.00-10.26%
  • Last Price$59.06
  • Previous Close$59.58
  • Change $-0.52
  • Open$57.76
  • Volume27,987,092
  • Avg. Volume (100-day)16,294,476
  • Market Capitalization$133.33B
  • Days Range $56.37 - $59.21
  • 52-week Range $42.48 - $68.34
  • Dividend Yield3.02%
  • Ex. Dividend Date01/02/2020
  • P-E29.8
  • EPS2
  • Earnings Date04/23/2020
  • SectorHealthcare
  • IndustryDrug Manufacturers - General
  • Avg. Analyst Rec.
  • Beta0.874
  • PEG Ratio1.19
  • Volatility0.42
  • Average True Range0.02
Bristol-Myers Squibb discovers, develops, and markets drugs for various indications, such as cardiovascular, oncology, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is leading in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.